Aventura Private Wealth’s Janux Therapeutics JANX Stock Holding History

Aventura Private Wealth’s Portfolio JANX Stock Details JANX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.35K	Hold	88	–	–	﹤0.01%	860
2026 Q1	$1.22K	Hold	88	–	–	﹤0.01%	782
2025 Q4	$1.21K	Hold	88	–	–	﹤0.01%	729
2025 Q3	$2.15K	Hold	88	–	–	﹤0.01%	670
2025 Q2	$2.03K	Hold	88	–	–	﹤0.01%	625
2025 Q1	$2.38K	Hold	88	–	–	﹤0.01%	592
2024 Q4	$4.71K	Buy	+88	New	+$4.66K	﹤0.01%	514

Other funds holding JANX

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Prosight Management Dallas, Texas $580M AUM 29.81% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

TCM

TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return

Aventura Private Wealth's JANX Position: Q2 2026 in Review

Aventura Private Wealth held its Janux Therapeutics (JANX) position steady in Q2 2026 at 88 shares worth $1.35K. The position accounts for ﹤0.01% of the portfolio, ranked #860.

Aventura Private Wealth first reported a position in JANX in Q4 2024 and has held it in 7 quarters since. The position peaked at $4.71K in Q4 2024. 197 funds tracked by Wall St. Rank hold JANX as of Q2 2026.

Aventura Private Wealth held 88 shares of Janux Therapeutics worth $1.35K as of Q2 2026.
Aventura Private Wealth left its Janux Therapeutics share count unchanged in Q2 2026.
Janux Therapeutics made up ﹤0.01% of Aventura Private Wealth's portfolio in Q2 2026, its #860 holding.
Aventura Private Wealth first reported a position in Janux Therapeutics in Q4 2024 and has held it in 7 quarters since.
Aventura Private Wealth's Janux Therapeutics position peaked at $4.71K in Q4 2024.
197 funds tracked by Wall St. Rank held Janux Therapeutics as of Q2 2026.

Based on Aventura Private Wealth's 13F filing for Q2 2026, filed 15 Jul 2026.